Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/3.7
Name: Drug, bio-affecting and body treating compositions >
Description:










Sub-classes under this class:

Class Number Class Name Patents
514/ Dermatitis 0
514/ Mouth treatment 0
514/ Liquid carrier, diluent or solvent 0
514/ Solid carrier or solid diluent 0
514/ Gaseous or gas emitting carrier or propellant 0
514/ Pill, lozenge, tablet or capsule 0
514/ Suppository, bougie or base 0
514/ Special designated ingredient 0
514/ Designated organic active ingredient containing (doai) 0
514/1 Designated organic active ingredient containing (doai) 691
514/769 Designated inorganic nonactive ingredient or elemental material other than water 191
514/772 Designated organic nonactive ingredient containing other than hydrocarbon 765
514/788.1 Solid synthetic organic polymer derived solely from hydrocarbon reactants as designated organic nonactive ingredient containing 33
514/789 Miscellaneous (e.g., hydrocarbons, etc.) 197
514/800 Lhrh like 204
514/801 Collagen, gelatin or derivatives thereof 217
514/802 Fibrinopeptides, blood-coagulation factors or derivatives 118
514/803 Kinin or derivatives 12
514/804 Phecmycin series or derivatives 5
514/805 Adrenocorticotropic hormone or derivatives 32
514/806 Somatostatin or derivatives 127
514/807 Oxytoxin, vasopressin or derivatives 62
514/808 Calcitonin or derivatives 63
514/809 Enkephalin or endorphin or derivatives 140
514/810 Addiction 103
514/814 Anemia 113
514/816 Anesthetic, general 110
514/817 Anesthetic, topical 147
514/818 Anesthetic, local 120
514/819 Antacid, oral 87
514/821 Antiarrhythmic 427
514/822 Anticoagulation 476
514/823 Antidote 89
514/824 Arteriosclerosis 630
514/825 Arthritis 719
514/826 Asthma 843
514/827 Astringent, nonfacial 24
514/829 Bite or sting 42
514/832 Blood substitute 179
514/833 Blood plasma extender 88
514/834 Coagulant 79
514/835 Caries 101
514/836 Chelate 231
514/837 Cholera 21
514/838 Cirrhosis 38
514/839 Contact lens treatment 126
514/841 Contraceptive 148
514/844 Cosmetic, facial 1,426
514/849 Cough and cold preparation 128
514/851 Cystic fibrosis 126
514/852 Dandruff 121
514/853 Decongestant 66
514/866 Diabetes 1,030
514/867 Diarrhea 206
514/868 Distemper 6
514/869 Diuretic 281
514/870 Edema 145
514/872 Emesis (motion sickness-nausea) 110
514/873 Emollient 260
514/874 Estrogenic agent (noncontraceptive) 70
514/875 Flea control 50
514/877 Gallstone 30
514/878 Geriatrics 65
514/880 Hair treatment (therapeutic-scalp) 469
514/882 Hemorrhoid preparation 68
514/883 Hodgkin's disease 29
514/884 Hypoglycemia 71
514/885 Immune response affecting drug 1,164
514/886 Inflammation, skin 545
514/888 Influenza 73
514/889 Interferon inducer 115
514/890 Irritant (e.g., tear gas, etc.) 7
514/891 Kidney stone 51
514/892 Laxative 93
514/893 Liver disorder 167
514/895 Malaria 94
514/896 Measles 11
514/898 Meningitis 14
514/899 Menstrual disorder 112
514/903 Multiple sclerosis 186
514/904 Multiple vitamins 131
514/906 Muscle relaxant 205
514/907 Muscular dystrophy 29
514/908 Leukemia 345
514/909 Obesity 334
514/912 Ophthalmic 1,056
514/916 Pyretic 138
514/917 Radioactive, anti- 35
514/918 Repellent 79
514/921 Shock 140
514/922 Side effect reduction by incorporation of a second designated ingredient 243
514/923 Sleep aid (insomnia) 96
514/924 Tuberculosis 50
514/925 Ulcer treatment 354
514/929 Vasodilator 426
514/930 Vasoconstrictor (nondecongestant) 60
514/931 Veneral disease 80
514/935 Uterine motility 41
514/936 Dmso containing 61
514/937 Dispersion or emulsion 1,385
514/944 Gel 1,196
514/945 Foam 230
514/946 Penetrant or absorbent (enhances penetration into subject treated) 399
514/948 Solid candy type 78
514/949 Naturally derived clay (e.g., bentonite, etc.) 75
514/950 Macromolecular (other than synthetic resins) 44
514/951 Powders, granules or particles of specified mesh or particle size 497
514/953 Shaped forms adapted for noningestible use other than suppository type (e.g., films, inserts, etc.) 171
514/957 Vapor emmitting composition 79
514/958 For smoking or inhaling 191
514/959 Breathing gases 53
514/960 Significant, tablet formulation (e.g., designated excipient, disintegrant, glydent or lubricant, etc.) 472
514/962 Capsule (e.g., gelatin, etc.) 314
514/964 Sustained or differential release type 328
514/966 Rectal 148
514/967 Vaginal 170
514/968 Urethral 42
514/969 Ointment or salve base 371
514/970 Containing designated ingredient to stabilize an active ingredient 516
514/974 Containing designated ingredient to reduce noxious effects of active ingredient (e.g., taste masking, odor reducing, etc.) 269
514/975 Characterized by the designated surfactant used 371


Patents under this class:

Patent Number Title Of Patent Date Issued
8709999 Substituted bicyclic HCV inhibitors Apr. 29, 2014
8703700 Bimacrocylic HCV NS3 protease inhibitors Apr. 22, 2014
8691757 Hepatitis C virus inhibitors Apr. 8, 2014
8691760 Peptides, pharmaceutical compositions comprising same and uses thereof Apr. 8, 2014
8680046 Inhibitors of viral integrase and methods of use Mar. 25, 2014
8673849 Lactadherin-derived peptides as antiviral agents Mar. 18, 2014
8652514 Antimicrobial peptides Feb. 18, 2014
8653025 Polyheterocyclic compounds highly potent as HCV inhibitors Feb. 18, 2014
8642531 Influenza antigen delivery vectors and constructs Feb. 4, 2014
8637456 Engineered polypeptide agents for targeted broad spectrum influenza neutralization Jan. 28, 2014
8633198 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase Jan. 21, 2014
8633230 Viral hepatitis treatment Jan. 21, 2014
8623815 TRIM5alpha mutants and uses thereof Jan. 7, 2014
8623814 Antiviral agents Jan. 7, 2014
8609105 Auristatin drug linker conjugates Dec. 17, 2013
8603965 Pharmaceutical composition for the prophylaxis and treatment of HIV infection and its use Dec. 10, 2013
8598116 Treatment of influenza virus infection Dec. 3, 2013
8592368 JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection Nov. 26, 2013
8563505 Hepatitis C virus inhibitors Oct. 22, 2013
8563506 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles Oct. 22, 2013
8551943 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles Oct. 8, 2013
8541377 Optimized dengue virus entry inhibitory peptide (DN81) Sep. 24, 2013
8536136 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Sep. 17, 2013
8524659 RNA virus-derived peptides with modified side chains Sep. 3, 2013
8524660 Polyalkylene polymer compounds and uses thereof Sep. 3, 2013
8486382 Method for treating cervical cancer Jul. 16, 2013
8481255 Scytovirin domain 1 related polypeptides Jul. 9, 2013
8476225 Antiviral compounds Jul. 2, 2013
8470771 Method and medicament for inhibiting the infection of influenza virus Jun. 25, 2013
8461107 HCV NS3 protease inhibitors Jun. 11, 2013
8445430 Cyclic carboxamide compounds and analogues thereof as of hepatitis C virus May. 21, 2013
8435939 Polypeptide anti-HIV agent containing the same May. 7, 2013
8431530 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles Apr. 30, 2013
8426359 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Apr. 23, 2013
8426360 Carbocyclic oxime hepatitis C virus serine protease inhibitors Apr. 23, 2013
8420596 Macrocyclic hepatitis C serine protease inhibitors Apr. 16, 2013
8420597 Antiviral compounds Apr. 16, 2013
8394764 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use Mar. 12, 2013
8377872 Cyclic P3 tripeptide hepatitis C serine protease inhibitors Feb. 19, 2013
8377873 HCV NS3 protease inhibitors Feb. 19, 2013
8377874 HCV NS3 protease inhibitors Feb. 19, 2013
8361958 Oximyl HCV serine protease inhibitors Jan. 29, 2013
8334255 Peptide and treatment for HIV-1 infection Dec. 18, 2012
8329197 Ex vivo uses of immunostimulatory combinations Dec. 11, 2012
8318147 Use of IL-29 for treating a dengue virus infection Nov. 27, 2012
8318662 Protein increasing cell infectivity of herpes simplex virus and use thereof Nov. 27, 2012
8314062 Macrocyclic compounds as antiviral agents Nov. 20, 2012
8299021 Macrocyclic inhibitors of hepatitis C virus replication Oct. 30, 2012
8293705 HCV protease inhibitors and uses thereof Oct. 23, 2012
8283310 Hepatitis C virus inhibitors Oct. 9, 2012











 
 
  Recently Added Patents
Encoding and/or decoding memory devices and methods thereof
Sample chamber for laser ablation inductively coupled plasma mass spectroscopy
Tunnel magnetoresistance read head with narrow shield-to-shield spacing
Modified and stabilized GDF propeptides and uses thereof
Method and system for providing cloud based network security services
Synchronization scheduling apparatus and method in real-time multi-core system
Low-staining room temperature curable coating composition
  Randomly Featured Patents
Load cell
Printed circuit boards
Color indicator apparatus for presence of oxygen
Command queuing apparatus and method of optical disk data reproduction system
Practice sleeve and ball
Growth of carbon nanotubes on carbon or metal substrates
Graphical user interface for a display screen or portion thereof
Method and plant for regulating the composition of the atmosphere in an enclosure
Highly weather-resistant electrodeposition coating composition
Frame forwarding installation